Roxborough Memorial Hospital Appoints New Chief Nursing Officer |
| March 18, 2005 |
Philadelphia, PA--Roxborough Memorial Hospital has announced the appointment of Natalie Glantz, B.S.N., M.S., as the institutions new chief nursing officer. Most recently Glantz served as Roxborough Memorial Hospitals director of cardiopulmonary services and as director of education and research. In her dual role, Glantz was responsible for the clinical and fiscal management of the institutions respiratory, cardiology and sleep lab services and the development and implementation of orientation, training and continuing education services for nursing and hospital personnel, as well as community-based education programs. With more than 22 years of experience in the healthcare setting, Glantz previously served as quality improvement coordinator at Philadelphia's Albert Einstein Medical Center and as quality assurance coordinator at the Hospital of the Medical College of Pennsylvania. An affiliate faculty member of the graduate and undergraduate nursing programs at Eastern University located in Radnor, PA and at Roxborough Memorial Hospitals School of Nursing, Glantz earned her Master of Science degree from St. Josephs University in Philadelphia and her Bachelor of Science degree in nursing from Widener University in Chester, PA. Glantz currently resides with her family in Blue Bell, PA. Roxborough Memorial Hospital is a 131-bed community hospital located at 5800 Ridge Avenue in Philadelphia, PA. The hospital, a part of Tenet Pennsylvania since 2002, has served the medical and health care needs of the Roxborough, Manayunk, East Falls and northwest section of Philadelphia for more than a century. Roxborough Memorial Hospitals School of Nursing has been educating nurses since 1898. The hospital is fully accredited by the Joint Commission on the Accreditation of Healthcare Organizations (JCAHO). To learn more about Roxborough Memorial, visit www.roxboroughmemorial.com. Certain statements in this release may constitute forward-looking statements. They are based on managements current expectations and could be affected by numerous factors and are subject to various risks and uncertainties. Certain of those risks and uncertainties are discussed in the Company's filings with the Securities and Exchange Commission, including the Company's transition report on Form 10-K for the 7-month period ended Dec. 31, 2002 and quarterly reports on Form 10-Q. Do not rely on any forward-looking statement, as we cannot predict or control many of the factors that ultimately may affect our ability to achieve the results estimated. We make no promise to update any forward-looking statement, whether as a result of changes in underlying factors, new information, future events or otherwise. |
